The CAMINEMS project aims at developing a new technology to sort, characterize and study rare cancer cells, mainly circulating tumour cells (CTC).
The instrument will combine:
a nanoparticles-based multiscale microfluidic system, able to capture rare tumour cells with a high yield, and
optical nano-observation and cell culture tools allowing the application of elaborate multi-biomarkers typing of these cells, and their study by cell biology methods.
Due to its microfluidic nature, our system is ideally suited to the development of minimally invasive sampling methods reducing risk and discomfort for patients. It will improve the power of CTC screening for treatment orientation and followup, in strong synergy with personalised medicine strategies. Finally, the CAMINEMS technology will also facilitate forefront research on the metastatic process and the development of new drugs.